Aligos Therapeutics announces positive data on chronic hepatitis B and MASH treatments at AASLD 2024
Aligos Therapeutics, Inc. a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced positive data from… read more.
